<DOC>
	<DOCNO>NCT00003364</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug radiation therapy may kill tumor cell . The best timing radiation therapy combination chemotherapy treat limited stage small cell lung cancer yet know . PURPOSE : Randomized phase III trial compare effectiveness radiation therapy give different time along combination chemotherapy treat patient limited stage small cell lung cancer .</brief_summary>
	<brief_title>Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether long term survival affect time thoracic radiotherapy patient limited stage small cell lung cancer receive combination chemotherapy . II . Determine whether development local recurrence distant metastasis affect time thoracic radiotherapy patient . OUTLINE : This randomize , multicenter study . Patients stratify center . All patient receive cyclophosphamide , doxorubicin , vincristine IV bolus alternate 3 day daily etoposide IV infusion 60-120 minute cisplatin IV infusion 30 minute . This treatment alternate every 3 week six course . Patients randomize thoracic radiotherapy either course 2 ( arm I ) course 6 ( arm II ) chemotherapy . Patients arm I give 1 week rest radiotherapy second course chemotherapy . If disease progression chemotherapy locoregional irradiation , repeat brain scan negative , patient receive prophylactic brain irradiation . Patients follow monthly first year every 2 month thereafter . PROJECTED ACCRUAL : This study accrue 398 patient .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm limited stage small cell lung cancer Limited disease define within hemithorax , mediastinum , ipsilateral supraclavicular node No evidence extensive disease ( i.e. , contralateral lung contralateral supraclavicular node ) No metastatic disease Measurable evaluable disease PATIENT CHARACTERISTICS : Age : Under 75 Performance status : ECOG 03 Life expectancy : At least 8 week Hematopoietic : WBC least 3,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 2 mg/dL Renal : Creatinine normal OR Creatinine clearance great 50 mL/min OR Pentetic acid/ethylenediaminetetraacetic acid clearance great 70 mL/min Cardiovascular : No myocardial infarction 3 month prior diagnosis No pericardial effusion Pulmonary : No pleural effusion see chest xray Pleural effusion identify CT allow , visible chest xray Other : No medical condition excludes use chemotherapy thoracic irradiation Must able tolerate prescribe study radiotherapy No malignant tumor least 3 year except nonmelanoma skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy No concurrent chemotherapy Endocrine therapy : Concurrent prednisone corticosteroid hypercalcemia allow Radiotherapy : No prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>limited stage small cell lung cancer</keyword>
</DOC>